Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.20.2
Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Subscriptions Receivable [Member]
Subscriptions Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2018 $ 34,292 $ 1,278,352 $ (602) $ (4,090) $ (1,959,982) $ (101) $ (652,131)
Balance, shares at Dec. 31, 2018 34,291,905              
Cash received on subscriptions receivable of OWP Ventures, Inc. 602 602
Common stock sold for cash $ 8,409 4,196,091 4,204,500
Common stock sold for cash, shares 8,409,000              
Common stock payable for services 160,000 160,000
Common stock payable for services, Shares              
Cashless exercise of common stock options $ 51 (51)
Cashless exercise of common stock options,Shares 51,040              
Issuance of common stock of OWP Ventures, Inc. on debt conversion $ 1,253 500,144 501,397
Issuance of common stock of OWP Ventures, Inc. on debt conversion, shares 1,253,493              
Common stock issued for services, OWP Ventures, Inc. $ 30 14,970 15,000
Common stock issued for services, OWP Ventures, Inc., shares 30,000              
Amortization of common stock options issued for services, OWP Ventures, Inc. 88,297 88,297
Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1) $ 1,323 (10,730) 101 (9,306)
Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1), shares 1,322,501              
Common stock cancelled pursuant to merger with OWP Ventures, Inc. $ (875) 875
Common stock cancelled pursuant to merger with OWP Ventures, Inc., shares (875,000)              
Amortization of common stock options issued for services 991,228 991,228
Beneficial conversion feature on convertible note 332,332 332,332
Loss on foreign currency translation (21,121) (21,121)
Net loss             (4,445,726)   (4,445,726)
Balance at Sep. 30, 2019 $ 44,483 7,391,508 160,000 (25,211) (6,405,708) 1,165,072
Balance, shares at Sep. 30, 2019 44,482,939              
Balance at Jun. 30, 2019 $ 39,923 4,503,966 138,911 (4,608,726) 74,074
Balance, shares at Jun. 30, 2019 39,922,899              
Common stock sold for cash $ 4,509 2,249,991 2,254,500
Common stock sold for cash, shares 4,509,000              
Common stock payable for services 160,000 160,000
Common stock payable for services, Shares              
Cashless exercise of common stock options $ 51 (51)
Cashless exercise of common stock options,Shares 51,040              
Amortization of common stock options issued for services 430,270 430,270
Beneficial conversion feature on convertible note 207,332 207,332
Loss on foreign currency translation (164,122) (164,122)
Net loss (1,796,982)   (1,796,982)
Balance at Sep. 30, 2019 $ 44,483 7,391,508 160,000 (25,211) (6,405,708) 1,165,072
Balance, shares at Sep. 30, 2019 44,482,939              
Balance at Dec. 31, 2019 $ 44,804 8,150,004 250,000 (16,248) (8,167,166) 261,394
Balance, shares at Dec. 31, 2019 44,804,305              
Common stock sold for cash $ 500 249,500 (250,000)
Common stock sold for cash, shares 500,000              
Common stock payable for services 45,000 45,000
Common stock payable for services, Shares                
Amortization of common stock options issued for services 1,875,623 1,875,623
Loss on foreign currency translation (28,700) (28,700)
Preferred stock units sold for cash $ 1,478,330
Preferred stock units sold for cash, shares 147,833                
Common stock issued for services $ 5,931 3,335,569 3,341,500
Common stock issued for services, shares 5,931,000              
Series A convertible preferred stock declared ($0.60 per share) (14,870) (14,870)
Net loss             (6,721,301)   (6,721,301)
Balance at Sep. 30, 2020 $ 1,478,330 $ 51,235 13,595,826 45,000 (44,948) (14,888,467) (1,241,354)
Balance, shares at Sep. 30, 2020 147,833 51,235,305              
Balance at Jun. 30, 2020 $ 400,000 $ 50,360 12,952,647 (44,451) (13,748,413) (789,857)
Balance, shares at Jun. 30, 2020 40,000 50,360,305              
Common stock payable for services 45,000 45,000
Common stock payable for services, Shares              
Amortization of common stock options issued for services 326,424 326,424
Loss on foreign currency translation           (497)     (497)
Preferred stock units sold for cash $ 1,078,330
Preferred stock units sold for cash, shares 107,833              
Common stock issued for services $ 875 331,625 332,500
Common stock issued for services, shares 875,000              
Series A convertible preferred stock declared ($0.60 per share) (14,870) (14,870)
Net loss             (1,140,054)   (1,140,054)
Balance at Sep. 30, 2020 $ 1,478,330 $ 51,235 $ 13,595,826 $ 45,000 $ (44,948) $ (14,888,467) $ (1,241,354)
Balance, shares at Sep. 30, 2020 147,833 51,235,305